New SEC Form D filing

PreciseDx, Inc., 2026-10-07

A new SEC Form D private-offering notice from New York, NY, a $3,699,998 filer-stated offering target in Healthcare & health tech. The source filing is one click away.

What this filing says

PreciseDx, Inc. site↗ Verified via SEC Form D

AI powered cancer diagnostics company offering rapid risk stratification tests for breast cancer, with a prostate cancer test in development

Filed 2026-10-07Filed to raise $3,699,998First money in 2026-09-23Raised so far $3,699,998HQ (as filed) New York, NYSector Healthcare & health tech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified precisedx.ai↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in New York →More Healthcare & health tech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source